E2F4 and pulmonary fibrosis: In addition, our previous study also found that mMSCs could further improve the epithelial injury and pulmonary fibrosis of ARDS mice by increasing differentiation into type II epithelial cells through p130/E2F4 pathway [15], indicating that there might be no side effects related to MSCs transplantation.